From experience, matching the right sites for a clinical trial can sometimes feel like searching for Cinderella the day after the ball.  

This is true for clinical trials in general, but becomes even more real when faced with the complex protocols and specialized needs of an early-phase oncology trial. Identifying the right clinical sites is paramount to ensure FPI, efficient patient enrollment, adherence to protocols, data efficacy and the overall integrity of the study. Site selection just isn’t something you can do half-baked. But how do you do it “right”?